PathMaker launches 1st human trial to test noninvasive ALS device | Phase 1 trial of MyoRegulator funded by MDA, CERF and NIH alsnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from alsnewstoday.com Daily Mail and Mail on Sunday newspapers.
PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.
Amyotrophic lateral sclerosis (ALS), also called Lou Gehrig’s disease is a neurodegenerative condition that causes damage to cells in the brain and spinal cord that is essential for movement.
A team of researchers from the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) and Massachusetts General Hospital (MGH) has developed a soft robotic wearable capable of significantly assisting upper arm and shoulder movement in people with ALS.